News
Class II recalls from the FDA indicate a potential risk to consumer safety where use or exposure to the product may cause ...
The trove of more than 200 letters is part of a pledge of transparency from the agency, with the intention to increase public ...
The FDA published a database of letters sent to drugmakers during the review process of medications that provide information on the agency's initial feedback or requirements for more data. These ...
A journey through the FDA’s newly released complete response letters gave glimpses into the journeys to market for Eli ...
The U.S. Food and Drug Administration has published more than 200 complete response letters, or decision letters, sent as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results